Invention Application
- Patent Title: RECOMBINANT FACTOR VIII-FC FOR TREATING HEMOPHILIA AND LOW BONE MINERAL DENSITY
-
Application No.: US17618808Application Date: 2020-06-18
-
Publication No.: US20220233650A1Publication Date: 2022-07-28
- Inventor: Susu DUAN , Katalin KIS-TOTH , Gaurav Manohar RAJANI , Joe SALAS
- Applicant: BIOVERATIV THERAPEUTICS INC.
- Applicant Address: US MA Waltham
- Assignee: BIOVERATIV THERAPEUTICS INC.
- Current Assignee: BIOVERATIV THERAPEUTICS INC.
- Current Assignee Address: US MA Waltham
- International Application: PCT/US2020/038444 WO 20200618
- Main IPC: A61K38/37
- IPC: A61K38/37 ; A61K47/68 ; A61P19/08
Abstract:
Disclosed herein are methods of treating subjects with hemophilia and low bone mineral density (BMD) with a chimeric protein comprising a coagulation factor and a Fc domain. In certain embodiments, the chimeric protein is rFVIIIFc. In certain embodiments, a subject to be treated has hemophilia A.
Information query
IPC分类:
